Related Experiment Video

Updated: Feb 23, 2026

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

8.1K

Venom Peptides: Improving Specificity in Cancer Therapy

Ravikiran Mahadevappa1, Rui Ma1, Hang Fai Kwok1

  • 1Faculty of Health Sciences, University of Macau, Avenida de Universidade, Taipa, Macau SAR, China.

Trends in Cancer
|September 5, 2017
PubMed

Insights

Venom peptides (VPs) show promise for targeted cancer therapy due to their specific action on cancer cells. Further study of VPs can lead to the development of novel peptide drugs for cancer treatment.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Oncology

Background:

  • Venom peptides (VPs) possess inherent specificity for cancer cells.
  • VPs influence key cancer processes like proliferation, invasion, migration, and angiogenesis.
  • VPs can modulate the tumor immune microenvironment.

Purpose of the Study:

  • To explore the potential of venom peptides (VPs) in cancer therapy.
  • To highlight the role of VPs in targeting cancer cell behavior and immune responses.
  • To inform the design of novel peptide-based cancer therapeutics.

Main Methods:

  • Literature review of studies on venom peptides and cancer.
  • Analysis of VP mechanisms affecting cancer cell proliferation, invasion, migration, and angiogenesis.
  • Examination of VP immunomodulatory effects in cancer.

Main Results:

  • Venom peptides demonstrate high specificity and selectivity for cancer cells.
  • VPs impact critical hallmarks of cancer, including cell growth and metastasis.
  • VPs show potential in altering immune responses within the tumor microenvironment.

Conclusions:

  • Venom peptides offer a promising avenue for developing targeted cancer therapies.
  • Understanding VP mechanisms can guide the creation of more effective and specific peptide drugs.
  • VPs represent a valuable resource for advancing precision oncology treatments.
Keywords:
combinatorial anticancer drugsimmunotherapytargeted cancer therapyvenom peptides

More Related Videos

Author Spotlight: Optimizing Scorpion Venom Extraction for Antivenom Production05:27

Author Spotlight: Optimizing Scorpion Venom Extraction for Antivenom Production

Published on: October 6, 2023

4.3K
Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.8K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
678